Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial responses, almost all patients progress to castration-resistant prostate cancer (CRPC). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback